Join us for the next Cards PRN JC on April 25th @ 3PM EST. We’ll be discussing lipid-lowering therapies w/ PGY2 CV residents Dr. Ami Patel and Dr. Aaron Adkisson as they review CLEAR Outcomes and LODESTAR Trials! teams.microsoft.com/l/meetup-join/…

Strong Abbott representation at MSHP Annual 2023! Great to connect with current and old colleagues! Minnesota Society of Health-System Pharmacists Abbott Northwestern

Join us for our NAPLEX Twitter Takeover this May!

Actual footage of conversations I have when I staff. Let’s just save us both some time and I’ll tell you what makes more sense and VORB from there🤣 #pharmacy

Present major project at MSHP North Star Residency Conference ✅ Have amazing and supportive pharmacy co-residents ✅ #MSHPNorthStar2023 Minnesota Society of Health-System Pharmacists

The correct answer: 2 mg PO daily! - Patient’s total IV dose of furosemide per day: 40 mg - Convert to furosemide PO: 80 mg - Convert to bumetanide PO: 2 mg Please review the loop diuretic overview below, created by Kaitlin Beyler and Sarah Wong! #NAPLEXTwitterTakeover

Hi new PharmD grads or anyone looking to test your knowledge! This week we're starting a Naplex Review Question Series - make sure to follow so you don’t miss out on any content!

Naplex Review! Which of the following is an equivalent daily dose to furosemide 40 mg PO BID?

Naplex Review! Which of the following can increase INR when taken with warfarin?

Answer: B. Oral equivalent dosing is furosemide 40 mg PO = torsemide 20 mg PO = bumetanide 1 mg PO. Furosemide IV to PO is 1:2 and bumetanide IV to PO is 1:1. Therefore furosemide 40 mg PO BID = furosemide 40 mg IV daily = torsemide 40 mg PO daily = bumetanide 2 mg PO daily.

#vacationmode #PuertoRico

Learn all about EKGs from Sarah Wong, PharmD including various changes that can be seen with drug toxicities, dysrhythmias, and more! How do you primarily use EKGs in your practice? 🫀⚡️ #TeachingTuesday

Cardiac medications in pregnancy and lactation 📝 What’s safe? What’s contraindicated? 👇 Cardiac-centered #WomensHealth

Knowledge Check! Which of the following medications is not suggested for initiation as GDMT in heart failure with preserved ejection fraction per the 2022 AHA guidelines?

Join us for the next Cards PRN JC on August 22nd @ 3PM EST. We’ll be discussing the various roles of AC/AT in the management of ischemic stroke with PGY2 CV residents Dr. Molly Kernan and Dr. Duy Tran as they review the ELAN and RESCUE BT2 trials! teams.live.com/dl/launcher/la…

📢 Next week our #CV Grand Rounds series continues with a presentation from @PeterEckmanMD, presenting on "Heart Failure Devices." 🩺 Access additional details and the webinar link here: bit.ly/3Uiaeeg

Sarah Wong presented a poster on "Outcomes with Bicarbonate-Based Purge vs. Heparin-Based Purge Solution in Patients Supported with Impella® Ventricular Assist Devices"

Thank you Minnesota Society of Health-System Pharmacists for a fantastic annual conference! Such a great experience being able to present with Matt Lillyblad and honored to be selected as the MSHP Outstanding Poster Award recipient! It’s always a fun time catching up with colleagues and being with my Allina family! ❤️

Excited to announce that after my PGY2 cardiology pharmacy residency I will be joining Novant Health as a cardiology clinical pharmacist at Forsyth Medical Center in Winston-Salem, North Carolina! Looking forward to this next chapter and new adventures!

Welcome to another #TeachingTuesday! Are you curious when to adjust doses or switch medications based on a patient's genetics? Dive into how genetics impact medication management! Join Meghan McNulty Meghan McNulty, PharmD, RPH as she explores the pharmacogenomics of cardiovascular meds!